ES2157985T3 - Metodo para la prevencion y el tratamiento de la mastitis bovina. - Google Patents

Metodo para la prevencion y el tratamiento de la mastitis bovina.

Info

Publication number
ES2157985T3
ES2157985T3 ES94925425T ES94925425T ES2157985T3 ES 2157985 T3 ES2157985 T3 ES 2157985T3 ES 94925425 T ES94925425 T ES 94925425T ES 94925425 T ES94925425 T ES 94925425T ES 2157985 T3 ES2157985 T3 ES 2157985T3
Authority
ES
Spain
Prior art keywords
treatment
prevention
mastitis
pharmaceutically acceptable
bovine mastitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94925425T
Other languages
English (en)
Inventor
John Edmondson Peel
Bruno Suri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2157985T3 publication Critical patent/ES2157985T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE MUESTRA UN METODO PARA EL TRATAMIENTO DE LA MASTITIS EN VACAS. EL METODO CONTEMPLA LA INYECCION INTRAMAMARIA O EL REMOJO DE LA TETA CON GALIDERMINA Y/O EPIDERMINA O UNA DE SUS SALES ACIDAS ACEPTABLES FARMACEUTICAMENTE. LA GALIDERMINA Y/O EPIDERMINA O UNA DE SUS SALES ACIDAS ACEPTABLES FARMACEUTICAMENTE SE PUEDE ADMINISTRAR ANTES DE LA INFECCION PARA SUPRIMIR DE FORMA EFECTIVA LA TASA, SEVERIDAD, Y DURACION DE LA INFECCION BACTERIANA CONSIGUIENTE, O PUEDE ADMINISTRARSE DESPUES DE LA INFECCION PARA TRATAR EFECTIVAMENTE LA MASTITIS.
ES94925425T 1993-08-20 1994-08-03 Metodo para la prevencion y el tratamiento de la mastitis bovina. Expired - Lifetime ES2157985T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93810588 1993-08-20
PCT/EP1994/002567 WO1995005844A1 (en) 1993-08-20 1994-08-03 Method for the prevention and treatment of bovine mastitis

Publications (1)

Publication Number Publication Date
ES2157985T3 true ES2157985T3 (es) 2001-09-01

Family

ID=8215016

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94925425T Expired - Lifetime ES2157985T3 (es) 1993-08-20 1994-08-03 Metodo para la prevencion y el tratamiento de la mastitis bovina.

Country Status (13)

Country Link
US (1) US5710124A (es)
EP (1) EP0789581B1 (es)
JP (1) JP3670280B2 (es)
AT (1) ATE201995T1 (es)
AU (1) AU689494B2 (es)
CA (1) CA2169847C (es)
DE (1) DE69427492T2 (es)
DK (1) DK0789581T3 (es)
ES (1) ES2157985T3 (es)
GR (1) GR3036573T3 (es)
NZ (1) NZ271650A (es)
PT (1) PT789581E (es)
WO (1) WO1995005844A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997048408A2 (en) * 1996-06-20 1997-12-24 Novartis Ag Method for the prevention and treatment of mastitis
US6406907B1 (en) 1999-02-26 2002-06-18 Iowa State University Research Foundation Bovine tumor necrosis factor receptor-1 and methods of use
CA2565457A1 (en) * 2004-05-06 2005-11-17 Molichem Medicines, Inc. Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions
CN100368016C (zh) * 2005-04-01 2008-02-13 北京大北农农业科技研究院 治疗奶牛乳房炎的乳房灌注液及其制备方法
US20100009405A1 (en) * 2005-06-29 2010-01-14 Wolfgang Minas Biosynthetic process for the preparation of gallidermin
ES2436614T3 (es) * 2005-07-28 2014-01-03 Biosynexus Incorporated Composiciones y procedimientos de tratamiento de bacterias
WO2007044745A1 (en) * 2005-10-11 2007-04-19 Biosynexus Incorporated Lantibiotic and mupirocin compositions for treating bacterial infections
EP2810695A1 (en) * 2013-06-06 2014-12-10 Ceva Sante Animale Compositions and Method for controlling infections in non-human mammals using acute phase proteins

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0181578B1 (de) * 1984-11-06 1991-09-04 Dr. Karl Thomae GmbH Antibiotisches Polypeptid, Verfahren zu seiner Herstellung und seine Verwendung
GB8811760D0 (en) * 1988-05-18 1988-06-22 Thomae Gmbh Dr K Antibiotic
US5334582A (en) * 1988-06-22 1994-08-02 Applied Microbiology, Inc. Pharmaceutical bacteriocin compositions and methods for using the same
US5304540A (en) * 1988-06-22 1994-04-19 Applied Microbiology, Inc. Pharmaceutical bacteriocin compositions and methods for using the same
AU623864B2 (en) * 1988-08-29 1992-05-28 Applied Microbiology, Inc Method of treating mastitis and other staphylococcal infections
US4980163A (en) * 1989-03-01 1990-12-25 Public Health Research Institute Of The City Of New York Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection
DE3938140A1 (de) * 1989-11-16 1991-08-08 Beiersdorf Ag Desodorierende kosmetische mittel
IL104364A (en) * 1992-01-17 1997-09-30 Applied Microbiology Pharmaceutical compositions containing bacteriocins

Also Published As

Publication number Publication date
NZ271650A (en) 1997-11-24
AU689494B2 (en) 1998-04-02
DE69427492D1 (de) 2001-07-19
GR3036573T3 (en) 2001-12-31
PT789581E (pt) 2001-11-30
JP3670280B2 (ja) 2005-07-13
ATE201995T1 (de) 2001-06-15
EP0789581A1 (en) 1997-08-20
CA2169847A1 (en) 1995-03-02
AU7534694A (en) 1995-03-21
EP0789581B1 (en) 2001-06-13
CA2169847C (en) 2006-02-14
DK0789581T3 (da) 2001-09-17
DE69427492T2 (de) 2002-04-18
WO1995005844A1 (en) 1995-03-02
US5710124A (en) 1998-01-20
JPH09502171A (ja) 1997-03-04

Similar Documents

Publication Publication Date Title
NO20014046L (no) Gabapentinderivater for forhindring og behandling av visceral smerte
ES2196556T3 (es) Formulacion en granulos para el tratamiento del tracto intestinal.
EA200100905A1 (ru) Фармацевтическая композиция, содержащая ингибиторы протонного насоса
IL124524A0 (en) Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors
ATE60229T1 (de) Implantierbares pharmakadepot mit gyrasehemmern.
ATE461698T1 (de) Gaba-analoga zur verhütung und behandlung gastrointestinaler beschwerden
ES2157985T3 (es) Metodo para la prevencion y el tratamiento de la mastitis bovina.
MY117109A (en) Injectable quinolone formulations.
DE69833377D1 (de) Pharmazeutische zusammensetzungen enthaltend lysostaphin allein oder in kombination mit einem antibiotikum zur behandlung von staphylokokkeninfektionen
WO2001035902A3 (en) Stabilized thyroxine compounds
EP1550443A4 (en) COMPOSITION AGAINST STRESS-BASED DISEASES
EP0974351A3 (en) Medicament for preventing and treating gastrointestinal damage
MY135972A (en) Egg anti-inflammatory composition and method of treating and preventing inflammation
AR039682A1 (es) Un medicamento para el tratamiento o prevencion del acne
WO1996000068A3 (en) Combination therapy for hiv infection
CA2314865A1 (en) Methods for preventing and treating mastitis
CO5031290A1 (es) Formulacion lo
AR022475A1 (es) Metodo para la prevencion o reduccion de eventos cardiovasculares asociados con intervencion coronaria.
AU2396900A (en) Treatment and prevention of hiv and other viral infections
WO1990006116A3 (de) Mittel zur behandlung von chronisch entzündlichen darmerkrankungen
FI970565A0 (fi) HIV-proteaasia inhiboiva yhdistelmä
WO2001058471A3 (en) Novel amino acid and peptide inhibitors of staphylococcus virulence
Patchett Phosphinic acid inhibitors of D-alanyl-D-alanine ligase.
RU2003116871A (ru) Способ лечения ран у животных в условиях длительной адаптации к гипокинезии
RU2002114397A (ru) Способ лечения мастита у коров

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 789581

Country of ref document: ES